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ABSTRACT 
Objective: Investigation of sildenafil citrate as an adulterant in the traditional liquid herbal products of the local market in Bangladesh. 
Methods: A reversed-phase high-performance liquid chromatographic (HPLC) method with photodiode array (PDA) detector system has been 
developed and validated for investigating the presence of synthetic phosphodiesterase 5 (PDE-5) enzyme inhibitor as an adulterant in the 
traditional herbal products. Nine of the liquid preparations (syrup), Balarista (A), Jinsant (B), Jernide (C), Bolarist (D), Sree Gopal Oil (E), 
Menostroge (F), Enerton (G), Ginseng (H) and Ginsin Plus (I), of six companies form local market of Bangladesh were investigated.  
Results: All the products (A–I) were found to contain sildenafil citrate as an adulterant. HPLC peak of the adulterant was confirmed by comparing 
retention time, UV spectra generated by PDA detector and peak spiking with the authentic sample of sildenafil citrate. The quantity of sildenafil 
citrate in A, B, C, D, E, F, G, H and I syrups were found to be 17, 22, 26, 25, 10, 24, 29, 22 and 17 mg/100 ml, respectively.  
Conclusion: The study indicated that all tested liquid herbal products contain sildenafil citrate as an adulterant. As PDE-5 inhibitors have severe 
side effects, possess drug-drug interaction and highly recommended to prescribe by registered physicians, the regulatory agency of Bangladesh 
should take necessary action to minimize the risk of patients.  
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PDE is a ubiquitous enzyme in the human cell that is the essential 
regulators of cyclic nucleotide signalling with diverse physiological 
functions. So far 11 subtypes of PDE (1–11) were identified. These 
enzymes are involved in various regulatory processes like ion-
channel functions, cell differentiation, apoptosis, muscle contraction 
etc. [1]. Nowadays, PDE is considered as an important molecular 
target in drug discovery. Pfizer initiated the medicinal chemistry 
research program to develop selective PDE-5 inhibitors for the 
treatment of hypertension and other cardiovascular diseases in 
1985. Sildenafil was synthesized in that project as an active drug [2]. 
During the clinical trial, sildenafil serendipitously found to have an 
effect in penile engorgement. This drug was eventually approved by 
Food and Drug Administration (FDA) of USA in1998 for the 
treatment of ED. Sildenafil is selective to PDE–5 compared to PDE1–
4, but it is less selective to PDE–6. As PDE–6 is found in the retinal 
cell, use of sildenafil is associated with visual side effects [2]. 
Moreover, sildenafil also showed several drug-drug interactions and 
contraindicated to organic nitrates. Concomitant use of sildenafil 
and organic nitrates might cause severe and fatal hypotension [3].  
Though sildenafil is approved as the prescription drug, it has great 
abuse potential for recreational purpose. Recently in the literature, it 
was reported that sildenafil is used as an adulterant in several 
traditional Chinese medicines that were marketed in Singapore and 
Denmark [4]. In the USA, the presence of sildenafil was reported in 
dietary supplements and bulk herbal products [5]. In Singapore, cases 
of 22 fatalities were reported during 1998–2009 due to the adverse 
reactions of adulterated herbal drugs and sildenafil was detected as 
one of the adulterants in those herbal products [6]. In India, one out of 
tested 85 Ayurvedic preparations from the local market was found to 
be adulterated with sildenafil [7]. Recently, In Bangladesh, a study was 
conducted using 35 traditional medicines and dietary supplements. 
The result indicated that 20 % traditional medicines and 70 % of the 
dietary supplements were found to contain sildenafil citrate as an 
adulterant. They also analysed two liquid dosages form among 35 
products and found that one liquid dose of traditional medicines 
contains the high concentration of sildenafil citrate as an adulterant. 
They concluded that more study is essential for the falsified products 
available in Bangladesh to observe the trends and find out the risk [8]. 
As traditional liquid medicines contain the high concentration of 
sildenafil citrate and there are many popular liquid herbal products 
available in the market as the sole remedies for physical and sexual 
weakness, it’s important to conduct the study in those products to 
protect the people from deadly effect. 
Many people of Bangladesh prefer to use liquid herbal products from 
their common believes that these products might have fewer side effects 
with maximum therapeutic benefit. However, if a patient with diabetes 
or ischemic heart diseases or related diseases uses sildenafil adulterated 
herbal products, it might possess a great health threat [3, 6, 9]. 
Therefore, monitoring for synthetic adulterants in marketed liquid 
herbal products which are most commonly used as strength and 
energy booster throughout Bangladesh is highly recommended for the 
safety of local people who solely depend on herbal remedies. In this 
study, we investigated the presence of specific PDE-5 inhibitor in the 
most popular marketed liquid herbal products in Bangladesh by HPLC 
system to confirm their safe use. 
MATERIALS AND METHODS 
Reagents and materials 
Sildenafil citrate INN as a standard PDE-5 inhibitor was purchased 
from Pol Pharma (Poland, Batch No. 101121128, Potency 99.99%). 
Potassium dihydrogen phosphate and phosphoric acid (85%) were 
purchased from Merck (Germany), water (HPLC grade) and 
acetonitrile (HPLC grade) from Active Fine Chemicals Ltd. (Dhaka, 
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Bangladesh). The Broncochin used for the treatment of respiratory 
tract diseases was purchased from Unani Herbal Ltd (Bangladesh) as 
the blank herbal product. The herbal products (A) Balarista syrup 
450 ml (Batch No. 071), (B) Jinsant syrup 450 ml (Batch No. 036) 
and (C) Jernide Syrup 100 ml (Batch No. 005) of Hamdard 
Laboratories (Bangladesh), (D) Bolarist Syrup 400 ml (Batch No. 
11), and (E) Sree Gopal Oil 50 ml (Batch No. 02) of Modern Herbal 
Research Garden (Bangladesh), (F) Menostroge syrup 400 ml (Batch 
No. 12) of MXN Homoeo Laboratory (Bangladesh), (G) Enerton 
syrup 200 ml (Batch No. 307003) of Square Herbal and 
Nutraceuticals Ltd. (Bangladesh), (H) Ginseng syrup 100 ml (Batch 
No. 03/12) of MaxFair and Company Ltd. (Bangladesh) and (I) 
Ginsin Plus Syrup 450 ml (Batch No. 001) of Muslim 
Pharmaceuticals (Unani, Rajshahi, Bangladesh) were purchased 
from local market of Bangladesh. 
Standard preparation 
The stock solution of standard sildenafil citrate was prepared by 
dissolving 1.5 mg/ml in methanol based on the solubility of the 
synthetic drug and stored in a refrigerator and brought to room 
temperature prior to use. The working solution was prepared by 
making a serial dilution of the stock solution with methanol to about 
0.0467 mg/ml. The injection volume was 20 μl for each working 
solution and the procedures were done for triplicate. 
Samples preparation 
One ml of each liquid herbal formulation was put into a 50 ml 
volumetric flask and taken to the volume with methanol. The flask 
was shaken vigorously and sonicated for 20 min at 40˚C 
temperature. The solutions were filtrated by filter paper to remove 
the unwanted materials, and the supernatant was again filtrated by a 
membrane filter to make a clear liquid solution of each herbal 
product. Then 1 ml of the clear solution of each formulation was 
taken in the HPLC vial and 20 μl of solution was injected.  
HPLC method development 
A Shimadzu SIL–20AHT prominence HPLC system controlled by 
LCsolution LC–Assist Software, version 2.1., with a Shimadzu SPD-
M20A prominence PDA detector (Shimadzu Corporation, Kyoto, 
Japan) was used. Phenomenex® Luna Analytical column (particle 
size: 5µ, stationary phase: C18 (ODS), pore size: 100 Å) was used 
under the isothermal condition at 40˚C. The system was pumped at a 
flow rate of 1.0 ml/min and full UV spectra were recorded on-line 
during the 30 min chromatographic run. The selection of the mobile 
phase was carried out in accordance with published literature [11] 
and consisted of (A) acetonitrile: 50 mmol potassium dihydrogen 
phosphate (adjust to pH 2.5 with phosphoric acid) (10:90, v/v) and 
(B) acetonitrile: 50 mmol potassium dihydrogen phosphate (adjust 
to pH 2.5 with phosphoric acid) (70:30, v/v); which were used in a 
gradient mode at a flow rate of 1.0 ml/min. The gradients system 
was: Tmin/A: B (V/V); T 0.01-5/100:0.00, T15/40:60, T20/0.00: 
100, T25/100:0.00, T30/100:0.00. 
HPLC method validation 
The validation of HPLC method was performed based on the 
published literature [10] with slight modification. Initially, the 
separation of sildenafil citrate was achieved by changing the ratio of 
mobile phase A and B. The best separation of the two drugs was 
achieved using gradient system and by retaining the pH 2.5 of buffer 
solution. The injection volume was 20 μl, and wavelength range was 
maintained at 190–400 nm using a PDA detector.  
The method was validated based on the linearity, accuracy, and 
precision. For the linearity, solutions of sildenafil citrate were 
prepared in the range of 0.75–0.0467 mg/ml and the method were 
performed in triplicate. Using these concentrations of standard 
drugs, the calibration lines were generated, and regression 
parameters were established. The concentrations of the standards 
and samples were evaluated by the established calibration lines.  
The percentage recovery, accuracy and precision of spiked sildenafil 
citrate at different concentration ranges were also evaluated. The 
concentration of spiked standards was also evaluated by using 
calibration lines. The limit of detection (LOD) and limit of 
quantification (LOQ) were also determined. For LOD and LOQ, the 
sample showing no signals at the retention time (RT) was 
considered as the blank and spiked sample that gave three times 
higher response in blank was taken as LOD and spiked sample that 
gave ten times response in blank was considered as LOQ.  
Spiking studies of herbal products (A–I) with standard 
For the confirmation of synthetic sildenafil citrate, all herbal 
products were spiked with 10 μg of standard sildenafil citrate in 
compliance with published literature [7]. In briefly, 1 mg of the 
standard was dissolved to make 1 mg/ml stock solution. The stock 
solution was diluted 10 times to make a solution of 100 μg/ml, then 
100 μl of this stock solution was put in a HPLC vial containing 900 μl 
solution of herbal product to make a working solution of 10μg/ml 
standard sildenafil citrate. The working solutions were injected into 
HPLC system for the confirmation of standard sildenafil citrate in 
nine herbal products (A–I). 
Quantification of sildenafil citrate in herbal products (A-I) 
For the quantification of the amount of sildenafil citrate in herbal 
products (A–I), all products were injected in triplicate under the 
developed operating condition and the mean amount of the three 
injections was recorded as the total amount of standard sildenafil 
citrate in herbal products as an adulterant.  
RESULTS  
For standard sildenafil citrate, three calibration standards were 
prepared to evaluate the relationship between the area under the 
curve and the concentration. The linearity of the relationship was 
determined for standard sildenafil citrate in a concentration range of 
0.75–0.047 mg/ml. The calibration curves were obtained using 
linear regression and were confirmed with the R2 values. Table 1 
showed the mean R2values and demonstrated that the standard 
calibration curves for sildenafil citrate are linear within the selected 
concentration ranges. To evaluate the LOD and LOQ, the different 
concentrations of the standard were mixed in blank herbal products 
(herbal product without PDE–5 inhibitors). Table 1 showed the 
values of LOD and LOQ. The results indicated that the LOD was 0.02 
μg and LOQ 0.07 μg/ml. 
  
Table 1: Linearity, LOD, LOQ 
Compound R2 LOD (μg) LOQ (μg) 
Sildenafil citrate 0.9997±0.0005 0.02 0.07 
The results are mean±standard deviation for n꞊ 3 determinations with detection at 293 nm  
 
The recovery study of the standard was determined using four 
concentration ranges. It was determined by different spiked 
concentrations of standard sildenafil citrate in the blank solvent. The 
calculation for the recovery studies was done using standard 
calibration lines. The result (table 2) indicated that the mean 
recoveries of sildenafil citrate were ranging from 92.4–105% and 
ensured that the method was suitable for analysis. From the 
recovery studies, accuracy and precision were also evaluated and 
shown in table 2. The limits of accuracy were between (-5.0)–7.60% 
and the limits of precision were in a range of 0.94–1.95%. The 
results of recovery studies, accuracy and precision indicated that the 
method was suitable for analysis. As all the results for validation of 
methods were suitable for analysis, therefore the analysis of herbal 
products was conducted in accordance with this method. 
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Table 2: Recovery, accuracy and precision studies 
Sample Spiked concentration 
(μg/ml) 
Calculated spiked concentration 
(μg/ml) 





40 42.0±0.82, 105.0 1.95 -5.0 
250 231±2.16 92.4 0.94 7.6 
800 748.25±8.14 93.5 1.09 6.47 
The results are mean±standard deviation for n꞊ 4 determinations with detection at 293 nm  
 
Fig. 1 showed the HPLC chromatogram of standard sildenafil citrate 
and herbal products (A–I). The chromatogram indicated the RT of 
standard sildenafil citrate at 13.6 min. The HPLC chromatogram also 
indicated that all herbal products (A–I) showed a large peak at 13.6 
min. The results revealed that all herbal products might contain 
sildenafil citrate. Although the sildenafil citrate and herbal product 
showed the similar peak at 13.6 min, sometimes different 
compounds can show the same retention time in HPLC analysis. 
Therefore, the ultraviolet spectrums (UV max) of identified peaks at 
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Fig. 1: HPLC chromatograms of standard sildenafil citrate and herbal products (A-I) 
 
Fig. 2 showed the HPLC chromatograms of A (1)–I (1) of herbal 
products and A (2)–I (2) of sildenafil citrate spiked in herbal 
products (A–I). The results indicated that the retention time of peaks 
of herbal products and the retention time of sildenafil citrate spiked 
in herbal products were similar. Moreover, the UV spectrums of 
these peaks were also similar in both herbal product and spiked 
herbal products. These results indicated that the retention time of 
peaks of herbal products at 13.6 min was due to the presence of 
sildenafil citrate. Based on the above analytical parameters, it was 
confirmed that all herbal products contained PDE-5 inhibitor such as 
sildenafil citrate. Therefore, the quantity of sildenafil citrate in each 
herbal product was also evaluated. 
 
 
Fig. 2: HPLC chromatograms of (1) herbal products (A-I), and (2) sildenafil citrate spiked in the herbal products (A-I) 
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Table 3 showed the quantity of sildenafil citrate as an adulterant in 
herbal products. The results indicated that the herbal products 
Balarista (A), Jinsant (B) and Jernide (C) of Hamdard Laboratory 
contained 17, 22 and 26 mg, respectively, Bolarist (D) and Sree 
Gopal Oil (E) of Modern Herbal contained 25 and 10 mg, 
respectively; Enerton (G) of Square Herbals contained 29 mg, 
Mengstroge (F) of MXN Homoeo contained 24 mg, Ginseng (H) of 
MaxFair contained 22 mg, and Ginsin Plus (I) of Muslim 
Pharmaceuticals contained 17 mg of sildenafil citrate in 100 ml 
syrup.
  
Table 3: Quantity of sildenafil citrate as an adulterant in herbal products (A-I) 
Sample Dosage Sildenafil citrate (mg/100 ml of syrup) 
A Liquid 17±1.5 
B Liquid 22±2.1 
C Liquid 26±1.8 
D Liquid 25±2.7 
E Liquid 10±1.1 
F Liquid 20±3.1 
G Liquid 29±2.8 
H Liquid 22±1.6 
I Liquid 17±1.1 
The results are mean±standard deviation for n꞊ 3 determinations 
 
DISCUSSION 
The results indicated that the herbal companies of Bangladesh use 
the large amount of synthetic PDE–5 inhibitors such as sildenafil 
citrate in their formulations. Some products even contain the high 
amount of sildenafil citrate compared to others. However, according 
to Pfizer labs, the recommended dose is 50 mg per day with a 
maximum dose must not exceed 100 mg [12]. So, the local people 
are unaware of their doses regimen as they buy these products from 
local market without knowing the presence of synthetic sildenafil 
citrate which possesses fatal effect on the human health with the 
high dose.  
Oral PDE-5 inhibitors are the treatment for the ED patients. The 
mechanism involves the release of nitrite oxide in the corpus 
cavernosum during the physical relationship. Then, Nitric oxide 
activates the enzyme guanylate cyclase, which increases the levels of 
cyclic guanosine monophosphate (cGMP), leading to smooth muscle 
relaxation in blood vessels and allowing blood flow in the corpus 
cavernosum. Based on the literature, this mode of action only 
happens in sexual intimation. FDA recommended sildenafil citrate 
for ED patients. However, it is suggested that the patients must take 
sildenafil citrate by consulting with the registered physician for the 
safe use. This drug must not be used without medical examination 
and prescription by the registered physician [2,13]. In Bangladesh, 
patients are buying these liquid herbal products without physical 
examination and prescription by the registered physician. The use of 
these herbal products might possess a serious unwanted effect on 
patient’s health. 
In addition, the sildenafil citrate also increases the risk of many 
cardiovascular diseases including heart attack, myocardial 
infarction, and sudden death. It’s also possible that the medication 
could interact with other drugs and may lead to fatal effect, for 
example, sildenafil citrate causes the synergic effect with alpha-
blockers which could lead to the dangerous health issue [13]. 
It is also recommended that sildenafil citrate must not buy from any 
nonstandard sources including online sources and products without 
labeling of sildenafil citrate. In this study, we found that all liquid 
herbal products mention that they use traditional medicines in their 
formulations. They also have no labeling about synthetic sildenafil 
citrate in their formulation. Moreover, it is also prohibited for the 
herbal companies to use any synthetic product in their formulation 
as herbal formulation must contain traditional medicines and use of 
synthetic medicines could cause counter interaction with natural 
medicines. 
However, In Bangladesh, most of the well reputed herbal companies 
are using synthetic sildenafil citrate as an adulterant in their liquid 
formulations. As the PDE-5 inhibitors cause the serious health 
problem, the use of these herbal products by patients may also cause 
fatal effect as the patients received these products without proper 
guidelines. Therefore, the government and the people of Bangladesh 
should be aware of these herbal products because the use of these 
products might cause patient death. 
CONCLUSION 
The study presents that all herbal products (A-I) were found to 
contain a synthetic PDE–5 inhibitors “sildenafil citrate”. The results 
suggested that as the synthetic PDE-5 inhibitors have several side 
effects, possesses severe drug-drug interactions and highly 
recommended to prescribe with caution for patients with various 
health problems, the use of synthetic agent in herbal products for 
the purposes of ED, physical and sexual weakness, and fatigue and as 
tonic might cause fatal effects. Therefore, the drug regulatory agency 
of Bangladesh should take necessary action urgently to minimize the 
future risk in patients. 
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